Liudmyla Oleksandrivna Pererva

Dr. Liudmyla Oleksandrivna Pererva

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Minerva Surgery
Verified
Journal Article
Closed access
LPLiudmyla Oleksandrivna Pererva
Liudmyla Oleksandrivna Pererva
VKVolodymyr Kopchak
Volodymyr Kopchak
GMGiovanni Marchegiani
Giovanni Marchegiani
KKKostiantyn Kopchak
Kostiantyn Kopchak
Article: Methods of preventing the occurrence of postoperative complications in patients with pancreaticoduodenectomy - Minerva Surgery 2021 May 04 - Minerva Medica - Journals

14 December 2022 in Klinicheskaia khirurgiia
Verified
Journal Article
Open access
PDF file
VKV. M. Kopchak
V. M. Kopchak
LPLiudmyla Oleksandrivna Pererva
Liudmyla Oleksandrivna Pererva
RSR. V. Saliutin
R. V. Saliutin
VKV. O. Kropelnytskyi
V. O. Kropelnytskyi
IKI. V. Khomiak
I. V. Khomiak
ADA. O. Danyliuk
A. O. Danyliuk
Objective. To elaborate the measures system, which permit to reduce the occurrence of pancreatic fistula and other severe complications after performance of pancreato–duodenectomy. Materials and methods. There were analyzed the results of treatment of 327 patients, in whom pancreato–duodenectomy was performed. In accordance to the scheme proposed, using the elaborated scale of risk for the postoperative pancreatic fistula occurrence with estimation of sarcopenia presence and application of certain prophylactic measures 98 patients were operated in period from November 2018 to December 2020 yr. (the main group). Into the control group 229 patients were included, operated on in the clinic from January 2015 to October 2018 yr. without estimation of risk for the pancreatic fistula occurrence and presence of sarcopenia. The method of pancreato–jejunoanastomosis formation was selected by operating surgeon. Results. Postoperative complications have occurred in 94 (41.0%) patients of the control group and in 28 (28.6%) patients of the main group (c 2 = 4.56, p=0.03). Clinically significant postoperative pancreatic fistula of B Degree have occurred in 9 (9.2%) patients of the main group, what was statistically significantly lower, than in the control group, in which postoperative pancreatic fistula of B or C Degree have occurred in 64 (27.9%) patients (c 2 = 11.6, p=0.0007). Lethality was 2.2% in the control group and 1.02% – in the main one. Conclusion. Introduction of the measures system elaborated have permitted to lower the postoperative pancreatic fistula rate statistically significantly from 27.9 to 9.2%, and of other postoperative complications – from 41.0 to 28.6% and lethality from 2.2 to 1.02%.

20 March 2023 in Modern medical technology
Verified
Journal Article
Open access
PDF file
VKV. M. Kopchak
V. M. Kopchak
VSV. P. Shkarban
V. P. Shkarban
LPLiudmyla Oleksandrivna Pererva
Liudmyla Oleksandrivna Pererva
ASA. O. Savitskiy
A. O. Savitskiy
VKV. O. Kropelnitskiy
V. O. Kropelnitskiy
VMV. P. Mihalchevskiy
V. P. Mihalchevskiy
Radical resection of pancreas during pancreatic ductal adenocarcinoma has a favorable effect on the patient’s survival rate and disease prognosis. Performance of PV/SMV resection during pancreatoduodenectomy is a routine procedure in leading pancreatology centers, increasing the possibility of R0 resections. Purpose of the study. Is to evaluate the criteria for the diagnosis of vascular invasion at the preoperative stage, to increase the proportion of R0 resections. The study included 73 patients with locally advanced tumors of the pancreatic head operated on in the pancreatic surgery department from 2019 to 2022. The range of operations included: Whipple pancreatoduodenectomy, pyloruspreserving pancreatoduodenectomy, and total pancreatoduodenectomy. The presence or suspicion of vascular invasion, the size, and the stage of the tumor at the preoperative stage were diagnosed according to the data of MSCT, MRI, ultrasonography, and endosonography. Histological examination was carried out according to the recommendations of the College of American Pathologist 2020. The first group 44 of patients who were made pancreatoduodenectomy with resection of PV/SMV, and the second group 29 patients without vascular resection. In the second group, a positive venous (smv) resection margin, R1 resection, had all patients according to the planned histological examination. During the preoperative examination, vascular invasion was suspected in 68,2% of patients in the first group, and 58.6% in the second, 58,6%, (x2 = 0,696; p = 0,403). According to histological examination, damage to the vascular wall was confirmed in 81,8% of cases among the first group of patients. A comparative assessment of the indicators of the two groups indicates that there is no significant difference in tumor size (t = 1,38; p = 0,085), localization, intraoperative data (operation time) (t = 1,19; p = 0,117), the number of postoperative complications (x2 = 0,027; p = 0,869), and the histological type of the tumor. Only intraoperative blood loss had statistical significant. Conclusions. The nowaday preoperative examination protocol allows diagnosing vascular or suspicion of it with sufficient probability and planning adequate surgical intervention. Performing a resection of PV/SMV during pancreaticoduodenectomy with pre- or intraoperative suspicion of vascular invasion allows to increase the number of R0 resections and improve the prognosis of the disease.

1 April 2025 in Military Medicine
Verified
Journal Article
Closed access
VKVolodymyr M Kopchak
Volodymyr M Kopchak
YKYuriy O Khilko
Yuriy O Khilko
LPLiudmyla Oleksandrivna Pererva
Liudmyla Oleksandrivna Pererva
ADArtem O Danyliuk
Artem O Danyliuk
ISIurii Snopok
Iurii Snopok
Introduction: Battlefield pancreatic injury (BPI) is rare and difficult to diagnose and treat. Publications on this topic are limited. The aim of this study was to analyze our initial experience in treating BPI since the beginning of the full-scale Russian invasion of Ukraine. Materials and Methods: We retrospectively analyzed the medical records of military personnel treated between February and December 2022. XLSTAT’s variable characterization tool, using an indicator called test value (TV), was used to assess possible associations between variables. Results: BPIs were found in 11 of 252 (4.4%) patients with an average age of 36.6 ± 10.1 years. The main cause of injury was explosion (6/11, 54.6%) and gunshot (2/11, 18.2%). Head of pancreas injuries were the most common (5/11, 45.5%), followed by distal pancreas injuries (4/11, 36.4%). Our treatment was predominantly interventional (5/11, 45.5%) and/or surgical drainage (4/11, 36.4%). Two patients (18.2%) were treated conservatively. One patient (9.1%) underwent cystojejunostomy for pseudocyst and another (9.1%) distal pancreatectomy. There was a positive association between the number of frontline operations and concomitant jejunal (TV 2.289; P = .022) and ileal (TV 2.211; P = .027) injuries. There was also a positive association between stoma formation at primary surgery and ileal injury (TV 2.000; P = .045) and pancreatic fistula and concomitant rib fractures (TV 2.484; P = .013). Conclusions: BPIs would be expected in victims with explosive damage to the upper body, often located in the head of the pancreas. Concomitant small bowel injury and rib fractures are associated with increased frequency of stoma formation, number of primary surgeries, and pancreatic fistula. Most patients can be successfully managed with interventional or surgical drainage without resection.

5 May 2019 in Klinicheskaia khirurgiia
Verified
Journal Article
Open access
PDF file
VКV. М. Коpchak
V. М. Коpchak
LPLiudmyla Oleksandrivna Pererva
Liudmyla Oleksandrivna Pererva
ОDО. V. Duvalko
О. V. Duvalko
VKV. V. Khanenko
V. V. Khanenko
SАS. V. Аndronik
S. V. Аndronik
VКV. О. Кropyvnytskyi
V. О. Кropyvnytskyi
Objective. To elaborate the system of measures with objective of lowering of the occurrence rate for pancreatic fistula and severe complications after pancreaticoduodenal resection (PDR). Маterials and methods. Results of treatment was analyzed for 143 patients, to whom pancreaticoduodenal resection performed. In accordance to the scheme proposed, using elaborated scale of the risk for occurrence of postoperative pancreatic fistula, were operated 56 patients in 2017 - 2018 yrs (the main group). Comparative group consisted of 87 patients, operated in the clinic in 2015 - 2016 yrs without estimation of the risk for postoperative pancreatic fistula occurrence and sarcopenia presence, and formation of pancreaticojejunoanastomosis have depended upon decision of a surgeon-operator. Results. The rate of occurrence of the postoperative complications was trustworthily higher in the comparison group (c2 = 5.8, p=0.01). In the main group a clinically significant pancreatic fistula of Grade В was observed in 1 of 7 patients with postoperative complications. In the comparison group pancreatic fistulas of Grades В or С were diagnosed in 15 of 26 patients with postoperative complications, which are trustworthily higher, than in the main group (c2 = 4.16, p=0.04). Conclusion. The system of measures elaborated gave the possibility to reduce the occurrence rate for pancreatic fistula significantly - from 17.2 tо 1.8% and severe postoperative morbidity - from 29.9 tо 12.5%.

30 March 2024 in General Surgery
Verified
Journal Article
Open access
PDF file
VKV. M. Kopchak
V. M. Kopchak
LPLiudmyla Oleksandrivna Pererva
Liudmyla Oleksandrivna Pererva
VKV. A. Kondratiuk
V. A. Kondratiuk
IKI. V. Khomiak
I. V. Khomiak
ODO. V. Duvalko
O. V. Duvalko
PAP. A. Azadov
P. A. Azadov
Objective — to determine the occurrence and management of postpancreatectomy haemorrhage in pancreatic cancer patients, as well as to identify effective treatment strategies to improve patient outcomes. Materials and methods. From January 2010 to December 2022, 878 patients who underwent radical pancreatic resections for malignant tumours were retrospectively analysed. Patients were divided into two groups. The main group consisted of 500 patients who were treated in the clinic from 2016 to 2022. In the main group, postpancreatectomy haemorrhage occurred in 31 (6.2%) patients. These patients were treated according to our diagnostic and treatment algorithm, using endovascular techniques as the first step of treatment. The comparison group consisted of 378 patients who were treated in our department from 2010 to 2015. In the comparison group, postpancreatectomy haemorrhage occurred in 20 (5.3%) patients. These patients were treated according to standard approaches. The definition of postpancreatectomy haemorrhage proposed by the International Study Group of Pancreatic Surgery was used in our research. Results. Out of 31 patients in the main group, 16 (51.6%) had endovascular embolisation. A total of 10 patients underwent endovascular occlusion, whereas 5 patients experienced cessation of bleeding with the use of a stent graft. Angiography did not detect the cause of bleeding in 3 (9.7%) individuals in the main group. They underwent laparotomy with subsequent haemostasis. 11 (35.5%) patients underwent open surgical interventions. In the main group, one (3.2%) patient died due to the emergence of infectious complications after laparotomy and subsequent haemostasis. 2 (10%) patients underwent endovascular haemostasis, while 15 (75%) patients underwent relaparotomy with haemostasis. In the comparison group, 6 (30%) patients died after open relaparotomies. Conclusions. The initial course of action for managing postpancreatectomy haemorrhage involves the implementation of endovascular techniques, wherein stent grafts are used to address bleeding originating from the main blood vessel. The application of advanced treatment strategies that optimised the use of minimally invasive endovascular techniques resulted in a notable decrease in the mortality rate associated with postpancreatectomy bleeding from 30% to 3.2% (χ2=7.3, p=0.006). Ensuring 24/7 access to endovascular treatment, which can be provided exclusively in high‑volume centres, is imperative for improving the treatment outcomes of patients with pancreatic and periampullary cancer.